The global nephrology and urology devices market size was estimated at USD 6.73 billion in 2025 and is projected to reach USD 11.73 billion by 2033, growing at a CAGR of 7.26% from 2026 to 2033. This growth is driven by the rising prevalence of chronic kidney disease, urolithiasis, and urinary system cancers, along with the increasing burden of diabetes and hypertension that contribute to long-term renal complications.
The growing adoption of minimally invasive and endourological procedures, including advanced catheterization, stenting, and stone management techniques, is further accelerating demand for specialized devices. In addition, expanding healthcare infrastructure, improved access to diagnostic and interventional urology services, and continuous innovation in biomaterials and device design are supporting procedural efficiency and patient outcomes. The shift toward outpatient and ambulatory surgical care, combined with increasing awareness of early diagnosis and treatment, is also contributing to sustained market expansion.
The rising prevalence of urological and renal disorders is a primary driver of growth in the nephrology and urology devices market. Conditions such as chronic kidney disease, kidney stones, and benign prostatic hyperplasia are increasing due to aging populations, sedentary lifestyles, diabetes, and hypertension. As these diseases progress, they require continuous clinical management, thereby increasing demand for a wide range of medical devices. For instance, CKD patients progress to end-stage renal disease, necessitating long-term dialysis supported by machines, dialyzers, and vascular access devices.
The growing incidence of kidney stones has led to a greater number of endourological procedures, such as ureteroscopy, which rely heavily on devices such as ureteral catheters, guidewires, and stone retrieval systems. In the case of BPH and other lower urinary tract disorders, increased patient volumes are driving the use of catheters, stents, and minimally invasive treatment devices. In addition, many of these conditions are chronic and recurrent, leading to repeated procedures and long-term device use, which significantly increases overall market demand. This sustained and expanding patient pool translates into higher procedural volumes and continuous consumption of disposable devices, making disease prevalence a key growth engine for the market.
This product will be delivered within 1-3 business days.
The growing adoption of minimally invasive and endourological procedures, including advanced catheterization, stenting, and stone management techniques, is further accelerating demand for specialized devices. In addition, expanding healthcare infrastructure, improved access to diagnostic and interventional urology services, and continuous innovation in biomaterials and device design are supporting procedural efficiency and patient outcomes. The shift toward outpatient and ambulatory surgical care, combined with increasing awareness of early diagnosis and treatment, is also contributing to sustained market expansion.
The rising prevalence of urological and renal disorders is a primary driver of growth in the nephrology and urology devices market. Conditions such as chronic kidney disease, kidney stones, and benign prostatic hyperplasia are increasing due to aging populations, sedentary lifestyles, diabetes, and hypertension. As these diseases progress, they require continuous clinical management, thereby increasing demand for a wide range of medical devices. For instance, CKD patients progress to end-stage renal disease, necessitating long-term dialysis supported by machines, dialyzers, and vascular access devices.
The growing incidence of kidney stones has led to a greater number of endourological procedures, such as ureteroscopy, which rely heavily on devices such as ureteral catheters, guidewires, and stone retrieval systems. In the case of BPH and other lower urinary tract disorders, increased patient volumes are driving the use of catheters, stents, and minimally invasive treatment devices. In addition, many of these conditions are chronic and recurrent, leading to repeated procedures and long-term device use, which significantly increases overall market demand. This sustained and expanding patient pool translates into higher procedural volumes and continuous consumption of disposable devices, making disease prevalence a key growth engine for the market.
Global Nephrology And Urology Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global nephrology And urology devices market report based on product, application, end use, and region:Product Outlook (Revenue, USD Million, 2021-2033)
- Ureteral Catheters
- Intermittent Catheters
- Foley / Indwelling Catheters
- External Catheters
- PCN Catheters
- Urinary Stents
- Metallic Ureteral Stents
- Polymer Ureteral Stents
- Silicone Stents
- Polyurethane Stents
- Hybrid Stents
- Stone Basket
- Disposable
- Reusable
- Urology Guidewires
- Nitinol Guidewires
- Stainless Steel Guidewires
- PTFE Guidewires
- Others
- Renal Dilators
- Disposable
- Reusable
- Other
Application Outlook (Revenue, USD Million, 2021-2033)
- Urolithiasis
- Urological Cancer & BPH
- Bladder Disorders
- Kidney Diseases
- Others
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Nephrology and Urology Devices Market Variables, Trends & Scope
Chapter 4. Nephrology and Urology Devices Market: Product Estimates & Trend Analysis
Chapter 5. Nephrology & Urology Devices Market: Application Estimates & Trend Analysis
Chapter 6. Nephrology & Urology Devices Market: End Use Estimates & Trend Analysis
Chapter 7. Nephrology & Urology Devices Market: Regional Estimates & Trend Analysis by Product, Application, End Use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Hollister Incorporated
- Coloplast
- Boston Scientific Corporation
- B. Braun SE
- Teleflex Incorporated
- Baxter
- Fresenius Medical Care AG & Co.
- Asahi Kasei Corporation
- Cook Group
- Terumo Corporation
- Nipro Medical Corporation
- BD
- Olympus
- Allium Medical
- Pnn Medical A/S
- Merit Medical Systems
- Convatec
- Ur24Technology, Inc.
- Sterimed Group
- Wellspect HealthCare
- Boehringer Laboratories, LLC
- Medline Industries, LP.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | April 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 6.73 Billion |
| Forecasted Market Value ( USD | $ 11.73 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
